115 related articles for article (PubMed ID: 17039675)
21. Standardization of skin tests for diagnosis and prevention of hypersensitivity reactions to oxaliplatin.
Pagani M; Bonadonna P; Senna GE; Antico A
Int Arch Allergy Immunol; 2008; 145(1):54-7. PubMed ID: 17703101
[TBL] [Abstract][Full Text] [Related]
22. A New Practical Desensitization Protocol for Oxaliplatin-Induced Immediate Hypersensitivity Reactions: A Necessary and Useful Approach.
Park HJ; Lee JH; Kim SR; Kim SH; Park KH; Lee CK; Kang BD; Beom SH; Shin SJ; Jung M; Park JW
J Investig Allergol Clin Immunol; 2016; 26(3):168-76. PubMed ID: 27326984
[TBL] [Abstract][Full Text] [Related]
23. Omalizumab for successful chemotherapy desensitisation: What we know so far.
Bumbacea RS; Ali S; Corcea SL; Spiru L; Nitipir C; Strambu V; Bumbacea D
Clin Transl Allergy; 2021 Dec; 11(10):e12086. PubMed ID: 34938440
[TBL] [Abstract][Full Text] [Related]
24. Hypersensitivity reactions to monoclonal antibodies: Classification and treatment approach (Review).
Pintea I; Petricau C; Dumitrascu D; Muntean A; Branisteanu DC; Branisteanu DE; Deleanu D
Exp Ther Med; 2021 Sep; 22(3):949. PubMed ID: 34335891
[TBL] [Abstract][Full Text] [Related]
25. Drug Desensitizations for Chemotherapy: Safety and Efficacy in Preventing Anaphylaxis.
Caiado J; Castells MC
Curr Allergy Asthma Rep; 2021 Jul; 21(6):37. PubMed ID: 34232411
[TBL] [Abstract][Full Text] [Related]
26. Presentation and Diagnosis of Hypersensitivity to Platinum Drugs.
Caiado J; Castells M
Curr Allergy Asthma Rep; 2015 Apr; 15(4):15. PubMed ID: 26130472
[TBL] [Abstract][Full Text] [Related]
27. Desensitizations for chemotherapy and monoclonal antibodies: indications and outcomes.
Hsu Blatman KS; Castells MC
Curr Allergy Asthma Rep; 2014 Aug; 14(8):453. PubMed ID: 24994467
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic tools for hypersensitivity to platinum drugs and taxanes: skin testing, specific IgE, and mast cell/basophil mediators.
Caiado J; Picard M
Curr Allergy Asthma Rep; 2014 Aug; 14(8):451. PubMed ID: 24951237
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of oxaliplatin desensitization protocols.
Cortijo-Cascajares S; Nacle-López I; García-Escobar I; Aguilella-Vizcaíno MJ; Herreros-de-Tejada A; Cortés-Funes Castro H; Calleja-Hernández MÁ
Clin Transl Oncol; 2013 Mar; 15(3):219-25. PubMed ID: 22855191
[TBL] [Abstract][Full Text] [Related]
30. Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review.
Makrilia N; Syrigou E; Kaklamanos I; Manolopoulos L; Saif MW
Met Based Drugs; 2010; 2010():. PubMed ID: 20886011
[TBL] [Abstract][Full Text] [Related]
31. Hypersensitivity reactions to oxaliplatin and other antineoplastic agents.
Syrigou E; Syrigos K; Saif MW
Curr Allergy Asthma Rep; 2008 Mar; 8(1):56-62. PubMed ID: 18377776
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis and management of hypersensitivity reactions caused by oxaliplatin.
Herrero T; Tornero P; Infante S; Fuentes V; Sánchez MN; De Barrio M; Baeza ML
J Investig Allergol Clin Immunol; 2006; 16(5):327-30. PubMed ID: 17039675
[TBL] [Abstract][Full Text] [Related]
33. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
Wong JT; Ling M; Patil S; Banerji A; Long A
J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
[TBL] [Abstract][Full Text] [Related]
34. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment.
Madrigal-Burgaleta R; Berges-Gimeno MP; Angel-Pereira D; Ferreiro-Monteagudo R; Guillen-Ponce C; Pueyo C; Gomez de Salazar E; Alvarez-Cuesta E
Allergy; 2013 Jul; 68(7):853-61. PubMed ID: 23647576
[TBL] [Abstract][Full Text] [Related]
35. Skin test protocol for the prevention of hypersensitivity reactions to oxaliplatin.
Pagani M; Bonadonna P
Anticancer Res; 2014 Jan; 34(1):537-40. PubMed ID: 24403513
[TBL] [Abstract][Full Text] [Related]
36. Hypersensitivity reactions to oxaliplatin: what nurses need to know.
Bonosky K; Miller R
Clin J Oncol Nurs; 2005 Jun; 9(3):325-30. PubMed ID: 15973843
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents.
Lee C; Gianos M; Klaustermeyer WB
Ann Allergy Asthma Immunol; 2009 Mar; 102(3):179-87; quiz 187-9, 222. PubMed ID: 19354063
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
